Institutional ownership in the company is 79.80% while the short ratio is 4.33.
The High price target of the company's Share is at $55 based on the calculations and analysis of 10 brokers. On 6/13/2016 Hafner Joseph A JR, Director sold 7,000 shares having total worth of $340,130 at the price of $48.59 per share, following the transaction a total of 63,766 shares owned by Hafner Joseph A JR. Ward bought the shares at $48.63 for a total of $301,506.00. It has market capitalization of $1.85B. This means that over the past quarter there has been an increase of insiders buying their shares of SYY in relation to earlier this year. According to a research note published on Jun 30, 2015, analysts at Deutsche Bank have lowered their rating on the company stock from Buy to Hold. SYSCO has a consensus rating of "Hold" and a consensus price target of $45.51. 2 said it's a Buy, 8 assigned Hold rating where 2 stated the stock as Underperform and 1 marked the stock as Sell. First Trust Advisors LP raised its position in SYSCO by 119.7% in the fourth quarter.
Regeneron Pharmaceuticals, Inc. has a market cap of $36.94B and has seen an average daily volume of 941334 over the past three months. Cadence Capital Management LLC raised its position in SYSCO by 64.2% in the fourth quarter.
The Company gained 0.08% and finished at $48.47. The year to date performance is at 20.40% with a 52 week high of -3.99% and a 52 week low of 40.33%. Sei Investments Co. now owns 664,209 shares of the company's stock valued at $27,233,000 after buying an additional 193,504 shares during the period. (NYSE:SYY) traded up 0.08% on Friday, hitting $49.80. The firm has a 50 day moving average of $48.84 and a 200 day moving average of $44.74.
Sysco Corporation has a market capital of 27544.48 at the moment and a profit to earnings ratio of 35.11.
SYSCO (NYSE:SYY) last announced its quarterly earnings results on Monday, May 2nd. The weekly performance of the company stands at -0.43 percent while it's 1-month and 3-month returns are -3.35 percent and 6.38 percent.
While Looking at the Earnings Estimates of the company, The Average Earnings Estimate for the Current Fiscal quarter is measured as $0.61 by 11 analysts. The firm had revenue of $12 billion for the quarter, compared to the consensus estimate of $11.87 billion.
Euclid Advisors Llc, which manages about $12.65B and $2.64B US Long portfolio, decreased its stake in Humana Inc (NYSE:HUM) by 19,928 shares to 14,172 shares, valued at $2.59M in 2016Q1, according to the filing.
Sysco Corporation along with its subsidiaries and divisions, is a North American distributor of food and related products primarily to the foodservice or food-away-from-home industry. The Firm provides products and related services to approximately 425,000 customers, including restaurants, healthcare and educational facilities, lodging establishments and other foodservice customers.